Answers are grounded in this paper and cite their sources.
Protein S -acylation (commonly known as palmitoylation) is a widespread reversible lipid modification, which plays critical roles in regulating protein localization, activity, stability, and complex formation. The deregulation of protein S -acylation contributes to many diseases such as cancer and neurodegenerative disorders. The past decade has witnessed substantial progress in proteomic analysis of protein S -acylation, which significantly advanced our understanding of S -acylation biology. In this review, we summarized the techniques for the enrichment of S -acylated proteins or peptides, critically reviewed proteomic studies of protein S -acylation at eight different levels, and proposed major challenges for the S -acylproteomics field. In summary, proteome-scale analysis of protein S -acylation comes of age and will play increasingly important roles in discovering new disease mechanisms, biomarkers, and therapeutic targets.
No takes yet. Share an insight, caveat, or question.
Wang et al. (2020) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: